← Back to Search

Procedure

Globe Mapping and Ablation System for Atrial Fibrillation (GPS-CA Trial)

N/A
Waitlist Available
Led By Southlake Regional Health Centre
Research Sponsored by Kardium Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up start to seven days after the end of the procedure
Awards & highlights

GPS-CA Trial Summary

This trial will study if a new heart mapping and ablation system is safe and effective for treating atrial fibrillation.

GPS-CA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~start to end of the procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and start to end of the procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acute isolation of all clinically relevant pulmonary veins confirmed by entrance block
Catheter dwell time
Fluoroscopy dose area product
+4 more

GPS-CA Trial Design

1Treatment groups
Experimental Treatment
Group I: Globe Mapping and Ablation SystemExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Globe Mapping and Ablation System
2021
N/A
~20

Find a Location

Who is running the clinical trial?

Kardium Inc.Lead Sponsor
6 Previous Clinical Trials
813 Total Patients Enrolled
5 Trials studying Atrial Fibrillation
721 Patients Enrolled for Atrial Fibrillation
Southlake Regional Health CentrePrincipal Investigator596 Davis Dr, Newmarket ON L3Y 2P9, Canada

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Performance and Safety of the Globe® Mapping and Ablation System With the GPS™ Module for the Treatment of Atrial Fibrillation
2021. "Performance and Safety of the Globe® Mapping and Ablation System With the GPS™ Module for the Treatment of Atrial Fibrillation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04486924.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top